N Engl J Med 1998; 338: 1650 1656. 58. Magnussen CG, Raitakari OT, Thomson R et al. Utility of currently recommended pediatric dyslipidemia classifications in predicting dyslipidemia in adulthood: evidence from the Childhood Determinants of Adult Health (CDAH) study, Cardiovascular Risk in Young Finns Study, and Bogalusa Heart Study. Circulation 2008; 117: 32 42. 59. Schrott HG, Bucher KA, Clarke WR et al. The Muscatine hyperlipidemia family study program. Prog Clin Biol Res 1979; 32: 619 646. 60. Jarvisalo MJ, Jartti L, Nanto-Salonen K et al. Increased aortic intima- media thickness: a marker of preclinical atherosclerosis in high-risk children. Circulation 2001; 104: 2943 2947. 61. Kavey RE, Allada V, Daniels SR et al. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 2006; 114: 2710 2738. 62. Olson RE. Atherogenesis in children: implications for the prevention of atherosclerosis. Adv Pediatr 2000; 47: 55 78. 63. Saland JM, Ginsberg H, Fisher EA. Dyslipidemia in pediatric renal disease: epidemiology, pathophysiology, and management. Curr Opin Pediatr 2002; 14: 197 204. 64. Saland JM, Ginsberg HN. Lipoprotein metabolism in chronic renal insufficiency. Pediatr Nephrol 2007; 22: 1095 1112. 65. National Kidney Foundation. KDOQI Clinical Practice Guideline for Nutrition in Children with CKD: 2008 update. Am J Kidney Dis 2009; 53: S1 124. 66. USRDS. US Renal Data System, USRDS 2003 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD, 2004. 67. 